we evaluated 155 patients with superficial bladder cancers ( stages ta , t1 , and tis ) and treated them with either intravesical bacillus calmette-guerin ( tice strain ) ( bcg ) or doxorubicin hydrochloride ( adriamycin ) , in a multicenter nonrandomized study .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin